Personal Experiences with Diagnostic Delay Among Axial Spondyloarthritis Patients: A Qualitative Study

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Introduction On average, patients with axial spondyloarthritis (axSpA) suffer from symptoms up to 13 or more years before diagnosis, contributing to psychological distress and healthcare burden Methods We conducted six semi-structured focus groups with 26 axSpA patients (from 3 rheumatology practices located in the states of Massachusetts, Colorado, and Pensylvania, USA) exploring early disease and diagnostic experiences. Verbatim transcripts were coded using a start list with emerging thematic codes added. A qualitative thematic analysis was performed Results Many participants described meandering and frustrating diagnostic journeys. Participants reported that intermittent axSpA symptoms and idiopathic pain contributed to physician confusion and delay in patients seeking care. Participants were sometimes perceived as somaticizing, drug-seeking, or “crazy.” Diagnostic delay led to frustration and mental suffering. Doctors “giving up” was considered profoundly negative. Stories of symptoms fell into five areas: (1) pain; (2) stiffness; (3) impact on sleep; (4) impact on daily activities; and (5) changes with weather. Self-advocacy and family advocacy were considered essential. Participants suggested wider use of HLA-B27 testing and development of a definitive diagnostic test Conclusion Most participants described significant suffering prior to axSpA diagnosis which could have been avoided with earlier intervention. Further research on the early disease experiences of axSpA patients is needed.
Funding Information
  • Novartis Pharmaceuticals Corporation (HEORUSV201137)
  • Timothy S. and Elaine L. Peterson (Charitable Contribution)

This publication has 33 references indexed in Scilit: